Key Characteristics of Immunotoxicants

 

The working group met biweekly by teleconference starting on September 8, 2020, and was hosted by Martyn Smith (UC Berkeley) and Lauren Zeise (OEHHA, CalEPA). The group was co-chaired by Dori Germolec (NTP/NIEHS) and Herve Lebrec (Amgen). The group examined the literature and developed 10 key characteristics (KCs) and are preparing a paper for publication.

Last NameFirst NameInstitutionEmailStakeholder
AndersonStacyU.S. CDCSAnderson4@cdc.govGovernment
BurlesonGaryBRTgburleson@brt-labs.comConsulting
CardenasAndresUC Berkeleyandres.cardenas@berkeley.eduAcademia
CorsiniEmanuelaUniversity of Milan, Italyemanuela.corsini@unimi.itAcademia
ElmoreSarahOEHHA, CalEPAsarah.elmore@oehha.ca.govGovernment
Germolec*DoriNTP/NIEHSgermolec@niehs.nih.govGovernment
KaplanBarbaraMississippi State Univ.BKaplan@cvm.msstate.eduAcademia
LawrencePaigeUniv. of RochesterPaige_Lawrence@URMC.Rochester.eduAcademia
Lebrec*HerveAmgenhlebrec@amgen.comPharma
LehmannGenieceU.S. EPALehmann.Geniece@epa.govGovernment
MaierCurtisGSKCurtis.C.Maier@gsk.comPharma
McHaleClionaUC Berkeleycmchale@berkeley.eduAcademia
MyersPeytonFDALaine.Myers@fda.hhs.govGovernment
PalladyMarcUniv. Paris Sudmarc.pallardy@universite-paris-saclay.frAcademia
RooneyAndrewNTP/NIEHSandrew.rooney@nih.govGovernment
SmithMartynUC Berkeleymartynts@berkeley.eduAcademia
ZeiseLaurenOEHHALauren.Zeise@oehha.ca.govGovernment
ZhangLuopingUC Berkeleyluoping@berkeley.eduAcademia

*Co-Chairs

Abbreviations: BRT, Burleson Research Technologies; CalEPA, California Environmental Protection Agency; CDC, Centers for Disease Control; FDA, Food and Drug Administration; GSK, GlaxoSmithKline; OEHHA, Office of Health Hazard Assessment; NIEHS, National Institute of Environmental Health Sciences; NTP, National Toxicology Program

Arrow-up